General Announcement::Thomson X partners WhiteCoat in Joint Venture

MEDIA RELEASE

Thomson X Partners WhiteCoat in Joint Venture to Launch a Market First

Mobile App for Women and Children

SINGAPORE, 15 December 2021 - Thomson X (TX), the digital arm of SGX-listed Thomson Medical Group, announced today a joint venture with Singapore's leading telehealth provider WhiteCoat to launch a mobile application that will offer seamless and personalised online-to-offline healthcare services to meet the health and wellness needs of women and children.

Integrating WhiteCoat's cutting-edge technology and virtual healthcare capabilities with Thomson Medical Group's medical expertise and its network of hospitals and clinics, the one-stop app will be the first of its kind, focused on digitally enhancing the delivery of Thomson Medical's brand of obstetrics and gynaecology and paediatric healthcare services to its patients.

When launched, the app will serve as the nexus for women at various stages of their lives, and their children to access virtual, clinic and home-based care in a comprehensive healthcare ecosystem, covering family planning, fertility and conception through to early childhood development. Besides complementing traditional face-to-face visits to the doctor, particularly during the ongoing pandemic, the app also aims to enhance the online-to-offline patient experience and optimise health outcomes.

TX, a newly established unit that charts the Thomson Group's technology roadmap, has within its mandate three business pillars: to provide proven innovations with faster go-to-market access, to digitalise and scale existing core businesses, and to research next-generation digital technologies and treatments.

Thomson Medical Group operates one of the largest private maternity hospitals in Singapore that delivers a fifth of all babies in Singapore annually. Outside of the hospital, the Group also operates a satellite network of women's and children's clinics delivering its brand of care to patients across the island.

Through strategic partnerships with digital health partners like WhiteCoat, TX aims to broaden accessibility to the Group's doctors and services, delivering a holistic omni-channel healthcare experience to a wider patient base through telemedicine and other digital health technology offerings.

As the tech enabler of the Group, TX catalyses advancements in telemedicine, digital healthcare products and treatment methods to enhance and engage its patient base and increase revenue opportunities for the Group.

Thomson Medical said that paediatricians and paediatric services from all its satellite paediatric centres have been onboarded to WhiteCoat's current telemedicine platform before the launch of the dedicated obstetrics and paediatrics app in 2022.

1

TX CEO-designate Kiat Lim said: "Thomson X was set up to harness technology to make healthcare more accessible and ensure that treatments and interventions can be delivered in a seamless, integrated manner that is more convenient and cost-efficient for our patients.

"We have been exploring HealthTech opportunities and our collaboration with a telehealth pioneer like WhiteCoat will put us in good stead to stay ahead of the medical technology curve."

Mr Lim added that the rising cost of raising a family, fertility challenges and mental wellness of mothers are some of the considerations and problems faced by couples and parents.

"We believe the pairing of Thomson's extensive hospital and clinics network with WhiteCoat's technological capabilities and approach to digitalising healthcare experiences will create holistic and integrated solutions at a time of rapidly rising demand for healthcare services," Mr Lim said.

Bryan Koh, WhiteCoat's Founder and Chief Executive Officer, said: "We are excited about the synergy between WhiteCoat's technology and expertise in digital healthcare, and Thomson's expertise in women's and children's health. This partnership cements our dedication and next steps to building a broader set of offerings across the spectrum of women's and children's health, founded on exceptional quality and accessible personalised care.

"Together, we will deliver next-generation health and wellness services, leveraging technology to provide actionable insights for our patients and best-in-class care that will redefine healthcare experiences as we know them today."

-THE END-

For media enquiries, kindly contact:

Warren Wu

Thomson Medical Group Limited

Mobile: [phone]

Email:[e-mail]

Winnie Yee

WhiteCoat Global Holdings Pte. Ltd.

Mobile: [phone]

Email:[e-mail]

2

About Thomson X Private Limited.

Thomson X charts the technology roadmap of Thomson Medical Group for continuous growth. Operating in synergy with the Group's core businesses and top-tier partners, Thomson X catalyses innovative digital products and services to cater to growing market demands. At Thomson X, we embrace the spirit of spontaneity, creativity, and passion. Thomson X is a subsidiary of Thomson Medical Group.

For more information, please visit: www.thomson-x.com.

About WhiteCoat Global Holdings Pte. Ltd.

WhiteCoat is the leading telehealth provider offering on-demand remote telemedicine services across Singapore and Indonesia. WhiteCoat provides a seamless end-to-end healthcare platform which supports primary care, specialist care, allied healthcare and home-based diagnostic testing needs.

WhiteCoat has formed strategic partnerships with the region's key insurers, corporates and healthcare providers to provide accessible and affordable high-quality medical care. WhiteCoat has also been appointed by the Ministry of Health (Singapore) as an official telemedicine partner for the Home Recovery Programme, leading the nation's fight against the COVID-19 pandemic.

VisitWhiteCoat | Downloadthe WhiteCoat app

3